Search "Ozempic cost without insurance" and you'll get wildly different numbers — $199, $349, $499, $997, $1,200, even $1,396. None of these are wrong. They're just answering different questions. The confusion isn't about pricing errors; it's about which price applies to which patient.
Ozempic (semaglutide) is FDA-approved for type 2 diabetes, and separately approved to reduce cardiovascular risk in adults with type 2 diabetes and heart disease, and to slow chronic kidney disease progression in adults with type 2 diabetes and CKD. It's also widely used off-label for weight loss, which is a big part of why demand — and pricing confusion — has exploded since 2023.
This guide walks through every price you'll actually see in 2026, who qualifies for each one, and how to figure out your real out-of-pocket cost before you commit to a pharmacy or a telehealth subscription.
Table of Contents
- The Four Prices You'll See for Ozempic
- List Price vs. Cash Price vs. Self-Pay Price
- Real Patient Scenarios
- Step-by-Step: Finding Your Real Price
- Decision Tree: Which Price Applies to You
- Eligibility Comparison Across Every Program
- Income Limit Comparison
- Covered Medications: Ozempic vs. Rybelsus vs. Wegovy
- How to Apply for Each Program
- Approval & Processing Timelines
- Renewing Your Enrollment
- Common Mistakes That Cost Patients Money
- Pros and Cons of Each Payment Route
- What If You Still Can't Afford It
- Frequently Asked Questions
The Four Prices You'll See for Ozempic
Before comparing programs, it helps to separate the four distinct numbers that all get labeled "the cost of Ozempic without insurance."
| Price Type | Typical 2026 Amount | Who Actually Pays This |
|---|---|---|
| List price (WAC) | ~$997–$1,029/month | No one directly — it's the manufacturer's reference price before any discount |
| Uninsured retail cash price | ~$1,200–$1,400/month | Patients who fill at a regular pharmacy with no coupon, card, or program applied |
| Manufacturer self-pay price (NovoCare / TrumpRx) | $199–$499/month | Uninsured or underinsured patients who enroll directly with Novo Nordisk or TrumpRx |
| Patient Assistance Program price | $0/month | Uninsured patients at or below 200% of the Federal Poverty Level |
The list price is not the cash price. A lot of confusion comes from headlines quoting the ~$1,000 list price as if it's what uninsured patients pay at checkout. In practice, the retail cash price (what a pharmacy actually charges with zero discounts applied) tends to run higher than list price, while Novo Nordisk's own self-pay programs run dramatically lower.
List Price vs. Cash Price vs. Self-Pay Price
Here's why the same drug generates such different numbers depending on where you look it up.
List Price (~$997–$1,029/month)
This is Novo Nordisk's Wholesale Acquisition Cost — the published starting price before pharmacy markups, insurer rebates, or manufacturer discounts. NovoCare publishes this figure directly. Novo Nordisk has announced a planned reduction to this list price taking effect in 2027, though that change won't materially affect patients already using self-pay pricing, since self-pay prices are already well below the current list price.
Uninsured Retail Cash Price (~$1,200–$1,400/month)
If you hand a prescription to a random retail pharmacy with no insurance, no coupon, and no manufacturer program applied, the price the register shows is often higher than list price — pharmacy benefit intermediary markups and pharmacy margin get layered on top. This is the number that shows up when people say Ozempic "costs" $1,200 or more per month.
Manufacturer Self-Pay Price ($199–$499/month)
Novo Nordisk sells Ozempic directly to self-pay patients through NovoCare Pharmacy, its own home-delivery pharmacy, at a fraction of the retail cash price. As of 2026:
- New self-pay patients: $199/month for the first two fills of the 0.25mg or 0.5mg starting doses.
- Ongoing self-pay, doses up to 1mg: $349/month.
- Ongoing self-pay, 2mg dose: $499/month.
The government's TrumpRx.gov platform, launched in early 2026 as part of a Most-Favored-Nation pricing agreement between the Trump administration and Novo Nordisk, lists Ozempic pen pricing starting at $199 and the Ozempic pill starting at $149 — closely mirroring NovoCare's own self-pay pricing, since both routes draw on the same manufacturer agreement.
You can't combine offers. The $199 introductory price, the ongoing self-pay price, and any commercial insurance savings card are separate payment tracks. Each fill uses exactly one of them — you can't stack a savings card on top of the self-pay price, and government-insurance beneficiaries (Medicare, Medicaid, TRICARE) are generally excluded from the manufacturer self-pay and TrumpRx cash tracks entirely.
Real Patient Scenarios
Scenario 1: Uninsured, new to Ozempic, starting dose
Maria is 34, has no health insurance, and her doctor just prescribed the 0.25mg starting dose for type 2 diabetes.
Best option: NovoCare Pharmacy or TrumpRx self-pay enrollment as a new patient.
$199/month for the first 2 fillsScenario 2: Uninsured, established patient, mid dose
James has been on Ozempic for eight months and is now stable on the 1mg dose. He doesn't have insurance through his new job yet.
Best option: Ongoing NovoCare self-pay pricing for doses up to 1mg.
$349/monthScenario 3: Uninsured, low income, meets PAP criteria
Denise lost her job, has no insurance, and her household income falls below 200% of the Federal Poverty Level for her household size.
Best option: Novo Nordisk's Patient Assistance Program, after a Medicaid denial letter is obtained.
$0/month if approvedScenario 4: Has commercial insurance, but plan excludes Ozempic
Alex has employer insurance, but his plan doesn't cover GLP-1s for his specific diagnosis code.
Best option: Compare the manufacturer savings card (if the plan partially covers it) against the self-pay price — self-pay is sometimes cheaper than a high-deductible copay.
As low as $25/month with card, or $349–$499 self-payStep-by-Step: Finding Your Real Price
Confirm your insurance status
Uninsured, commercially insured, or on a government plan (Medicare, Medicaid, TRICARE) — this single fact determines which pricing tracks are even available to you.
Check your household income against PAP limits
If you're uninsured and your income is at or below 200% of the Federal Poverty Level, the free Patient Assistance Program should be your first stop — it beats every cash-pay option.
Compare NovoCare and TrumpRx self-pay pricing
If you don't qualify for PAP, compare the current self-pay price on both novocare.com and trumprx.gov for your specific dose — pricing can shift, and checking both takes a few minutes.
If insured, ask about the manufacturer savings card
Commercially insured patients whose plan covers Ozempic for an approved indication may qualify for a savings card that brings the copay to as low as $25/month, separate from the self-pay track.
Check your local pharmacy price as a backup
Use our Drug Price Checker to compare cash prices near you, and check both GoodRx and Inside Rx — see our GoodRx vs. Inside Rx comparison — in case a local price beats the manufacturer's self-pay rate for your specific pharmacy.
Decision Tree: Which Price Applies to You
Step 1: Are you enrolled in Medicare, Medicaid, or TRICARE?
✔ Yes → Self-pay and TrumpRx pricing generally don't apply to you; ask your plan about Part D coverage or the 2026 Medicare GLP-1 pilot pricing instead.
✖ No → Continue to Step 2.
Step 2: Do you have commercial insurance that covers Ozempic for your diagnosis?
✔ Yes → Ask about the manufacturer savings card; compare it against self-pay pricing before assuming insurance is cheaper.
✖ No → Continue to Step 3.
Step 3: Is your household income at or below 200% of the Federal Poverty Level?
✔ Yes → Apply for the Patient Assistance Program — it's free if approved.
✖ No → Continue to Step 4.
Step 4: Are you a new self-pay patient on the 0.25mg or 0.5mg dose?
✔ Yes → You likely qualify for the $199/month introductory offer through NovoCare or TrumpRx.
✖ No → You're on the ongoing self-pay track: $349/month (up to 1mg) or $499/month (2mg dose).
Eligibility Comparison Across Every Program
| Program | Insurance Required? | Income Limit? | Government Plan OK? |
|---|---|---|---|
| NovoCare Pharmacy self-pay | No — designed for uninsured/self-pay | No income limit | Excluded |
| TrumpRx.gov | No | No income limit | Excluded |
| Manufacturer savings card | Yes — commercial insurance | No income limit | Excluded |
| Patient Assistance Program | No — must be uninsured | Yes — 200% FPL | Case-by-case for Medicare |
| Medicare Part D (standard diabetes coverage) | Requires Part D enrollment | No income limit (coverage itself) | Medicare only |
Income Limit Comparison
Only one path to affording Ozempic actually checks your income. Everything else — including the two cheapest cash-pay routes — has no income requirement at all.
| Household Size | Ozempic PAP Limit (200% FPL) | Extra Help / LIS Limit (Medicare, approximate) |
|---|---|---|
| 1 Person | ~$31,300 | Varies by asset test — see Extra Help (LIS) |
| 2 People | ~$42,300 | Varies by asset test — see Extra Help (LIS) |
| 3 People | ~$53,300 | Varies by asset test — see Extra Help (LIS) |
| 4 People | ~$64,300 | Varies by asset test — see Extra Help (LIS) |
Income only matters for one path. If your income is above the PAP limit, that doesn't shut you out of affordable Ozempic — it just means the self-pay track (NovoCare or TrumpRx) is your best option instead of the free program. Most people searching "Ozempic cost without insurance" end up here, not in the income-based track.
Covered Medications: Ozempic vs. Rybelsus vs. Wegovy
Novo Nordisk sells three semaglutide products, and mixing them up is one of the most common — and expensive — mistakes patients make when comparing prices.
| Product | Form | FDA-Approved For | PAP Eligible? | Self-Pay Starting Price |
|---|---|---|---|---|
| Ozempic | Injection | Type 2 diabetes; cardiovascular and kidney risk reduction in T2D | Yes (≤200% FPL, uninsured) | $199/month (intro) |
| Rybelsus | Oral tablet | Type 2 diabetes | Yes | Varies — check current NovoCare pricing |
| Wegovy | Injection | Chronic weight management; certain cardiovascular risk reduction | Not through PAP | $199/month (intro) |
Same drug, different label, different rules. Ozempic and Wegovy are both semaglutide, but Wegovy is FDA-approved specifically for weight management and is not available through Novo Nordisk's Patient Assistance Program. If your prescriber wrote for weight loss, you're working with Wegovy's separate self-pay and coverage rules, not Ozempic's — even though the injection itself is chemically similar.
How to Apply for Each Program
NovoCare Pharmacy Self-Pay
- Go to novocare.com and select the self-pay / cash-pay enrollment option for Ozempic.
- Provide your prescription details — your prescriber can send it electronically or you can upload it.
- Confirm your dose and select the applicable pricing tier (new patient vs. ongoing).
- Set up home delivery; NovoCare Pharmacy ships directly to your address.
TrumpRx.gov
- Visit trumprx.gov and search for Ozempic pen or Ozempic pill.
- Confirm eligibility (self-pay, non-government-insurance patients).
- Complete the order with your prescription information.
- Select delivery — orders are fulfilled through participating pharmacy partners.
Patient Assistance Program (Free, Income-Based)
- Confirm your household income is at or below 200% FPL and that you're uninsured.
- Obtain a Medicaid denial letter if your state's Medicaid income threshold applies to you.
- Complete the patient section of the application; have your prescriber complete the clinical section.
- Submit with proof of income; approved medication ships to your home through the program's specialty pharmacy.
For the full income-eligibility breakdown, required documents, and application walkthrough, see our dedicated Novo Nordisk Patient Assistance Program guide.
Approval & Processing Timelines
| Path | Typical Timeline |
|---|---|
| NovoCare self-pay enrollment | Same day to a few business days for first shipment |
| TrumpRx.gov order | A few business days for processing and shipping |
| Patient Assistance Program (complete application) | 1–2 business days for a decision once documents are complete |
| Commercial insurance with prior authorization | Typically within two business days once your prescriber submits complete clinical information — see our prior authorization guides |
Renewing Your Enrollment
- Self-pay (NovoCare/TrumpRx): Pricing is ongoing month to month; there's no annual renewal, but the introductory $199 rate only applies to your first two fills — confirm your current tier before each refill.
- Patient Assistance Program: Enrollment typically runs about 12 months; you'll need to resubmit income and insurance documentation to continue.
- Manufacturer savings card: Cards are often reissued annually or when your plan year changes; check for expiration dates on your card.
If your income, insurance, or employment status changes mid-year, re-check which pricing track you qualify for. Someone approved for the free PAP who then gains commercial insurance, for example, needs to switch to the savings card track — the programs aren't interchangeable mid-enrollment.
Common Mistakes That Cost Patients Money
- □ Assuming the ~$1,000 list price is what you'll pay at self-pay checkout — it's not.
- □ Confusing Ozempic pricing with Wegovy pricing because both are semaglutide.
- □ Trying to combine a savings card with the self-pay cash price — only one applies per fill.
- □ Not checking TrumpRx and NovoCare pricing side by side before committing to a telehealth subscription markup.
- □ Applying for the Patient Assistance Program with income above the limit instead of using self-pay pricing.
- □ Assuming Medicare or Medicaid beneficiaries can use the manufacturer self-pay cash price — they generally cannot.
- □ Letting a Patient Assistance Program enrollment lapse without renewing documentation.
Pros and Cons of Each Payment Route
| Route | Pros | Cons |
|---|---|---|
| NovoCare self-pay | Predictable pricing; direct manufacturer shipping; no insurance needed | Price rises after the first two fills; excludes government-insurance patients |
| TrumpRx.gov | Comparable or lower pricing; government-backed platform | Newer platform; fulfillment logistics still maturing in some regions |
| Patient Assistance Program | Free medication if approved | Strict income limit; slower paperwork; annual renewal required |
| Commercial insurance + savings card | Can be cheapest option if plan covers the drug ($25/month possible) | Depends entirely on formulary coverage and prior authorization approval |
| Retail cash price, no discount | No enrollment or paperwork required | By far the most expensive option — almost never the right choice |
What If You Still Can't Afford It
If none of the standard tracks bring the price into reach, a few additional resources are worth checking before giving up on the medication entirely.
- NeedyMeds maintains a searchable database of additional assistance programs, diagnosis-based grants, and free/low-cost clinics.
- BenefitsCheckUp, from the National Council on Aging, screens for a wide range of benefit programs — useful for older adults who may qualify for help beyond Extra Help.
- Ask your prescriber about disease-specific foundation grants, which sometimes cover diabetes medications independent of the manufacturer's own program.
- If Ozempic specifically remains out of reach, ask your prescriber about older, lower-cost diabetes medications as a bridge while you sort out longer-term coverage — see our broader patient assistance programs directory for options across manufacturers.
Bottom Line
The ~$1,000 list price you see in headlines is almost never what an uninsured patient actually pays for Ozempic in 2026. Between Novo Nordisk's own self-pay program, the TrumpRx government platform, and the income-based Patient Assistance Program, most patients land somewhere between $0 and $499 a month — a fraction of the retail cash price.
The fastest way to find your number is to check your insurance status and income against the eligibility table above, then compare NovoCare and TrumpRx pricing directly for your specific dose before filling anywhere else.
Ready to check your price?
Compare current self-pay pricing directly on the official NovoCare portal, or check income-based eligibility for the free Patient Assistance Program.
Go to NovoCare → Check PAP EligibilityFrequently Asked Questions
The list price is around $997 to $1,029 per month, and an uninsured cash price at a regular retail pharmacy can run $1,200 or more. Most uninsured patients actually pay far less by using Novo Nordisk's self-pay pricing through NovoCare Pharmacy ($199 to $499 per month depending on dose) or the TrumpRx government platform, which offers similar pricing.
For most uninsured patients, NovoCare Pharmacy's self-pay program or TrumpRx.gov offer the lowest guaranteed prices, starting around $199 per month for new patients on the lower doses. Patients who meet strict income limits may also qualify for Novo Nordisk's Patient Assistance Program, which provides Ozempic at no cost.
No. Ozempic (semaglutide) has no FDA-approved generic equivalent as of 2026, which is why cash prices remain high compared to older diabetes medications like metformin. Compounded semaglutide exists in some markets but is not the same as the FDA-approved brand product and carries different risks and regulatory status.
Medicare Part D can cover Ozempic when prescribed for its FDA-approved diabetes or cardiovascular-risk indications, subject to your plan's formulary, tier, and any prior authorization rules — you'll typically still owe a copay or coinsurance. Coverage for Ozempic prescribed purely for weight loss is a separate, more limited pathway tied to 2026 policy changes for anti-obesity medications. See our Medicare Part D guide for details.
You can search Ozempic on GoodRx or Inside Rx, but because there's no generic version, brand-name coupon savings are usually smaller than what Novo Nordisk's own self-pay or savings card programs offer. It's worth comparing all three — see our GoodRx vs. Inside Rx comparison — before filling.
Novo Nordisk has announced plans to reduce Ozempic's U.S. list price in 2027, and separate government-negotiated pricing through TrumpRx and Medicare has already lowered what many patients pay in 2026. Current self-pay cash prices are generally already below the list price, so a future list-price cut may have limited effect on patients already using self-pay pricing.
Not on your own. Ozempic and Wegovy are approved for different uses and priced under separate programs, and your prescriber has to write for the specific product and dose that matches your diagnosis. If cost is the deciding factor, ask your prescriber which product's pricing and coverage rules actually fit your situation.
Yes. Both NovoCare and TrumpRx price the 2mg dose higher ($499/month) than doses up to 1mg ($349/month), and new patients on the 0.25mg or 0.5mg starting doses qualify for the lowest introductory rate. If your prescriber increases your dose over time, expect your monthly self-pay price to change accordingly.
Compounded semaglutide is not FDA-approved as a standalone product the way brand-name Ozempic is, and its availability and legal status have shifted as supply shortages have eased. Discuss the safety, sourcing, and regulatory status of any compounded product with your prescriber before considering it as a cost workaround.
How We Researched This Guide
References
- NovoCare. Ozempic List Price and Savings Offer Program.
- Novo Nordisk US. Product and Pricing Announcements.
- Lilly Cares Foundation. Patient Assistance for Eli Lilly Medications.
- Eli Lilly and Company. Pricing and Access Information.
- Medicare.gov. Part D Prescription Drug Coverage.
- Centers for Medicare & Medicaid Services. GLP-1 Coverage Policy Updates.
- U.S. Food & Drug Administration. Semaglutide Product Approvals.
- NeedyMeds. Patient Assistance Program Directory.
- National Council on Aging. BenefitsCheckUp.
Related Resources
Related Pricing & Savings Guides
- Novo Nordisk Patient Assistance Program (Full Application Guide)
- Patient Assistance Programs: Full Directory
- Drug Price Checker: Compare Cash Prices Near You
- Manufacturer Savings Cards Explained
- GoodRx vs. Inside Rx: Which Saves You More?
- Insulin Savings Programs: 2026 Guide
- Medicare Part D Explained
- Extra Help (LIS): Income Limits & How to Apply
- Prior Authorization Guides by Insurance Type
Editorial Policy: Refill Relay content is researched using publicly available manufacturer pricing materials, federal poverty guidelines, and standard industry pricing practices. Every article is reviewed for clarity, accuracy and usefulness before publication.